Outlook Therapeutics closes $5.0M offering of common stock and warrants

Outlook Therapeutics, Inc.

20M shares + 20M warrants sold at $0.25/unit; gross proceeds ~$5.0M, net ~$4.0M.
Warrants exercisable immediately at $0.25, expire in 5 years; includes 4.99%/9.99% beneficial ownership limitation.
H.C. Wainwright placement agent, receiving 7% cash fee and 1.4M warrants at $0.3125.
Company agreed to one-year ban on variable rate transactions and lock-up agreements.
Offering closed March 25, 2026; net proceeds ~$4.0M for general corporate purposes.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.